Asthma


Definition
a generally chronic condition that is characterized by recurring attacks of wheezing, coughing, and labored breathing; it may be caused by allergies, physical exertion, chemical irritation, or emotional stress. (From a Greek word meaning "panting.")
 
Radiographic Appearance

Typical findings in an asthmatic chest radiograph include hyperexpanded lungs evident best with flattened diaphragms and narrowed cardiac shadow and mediastinum. On a lateral projection the chest may appear "barrel" shaped.

The radiograph may be normal or show hyperinflation. Areas of segmental and subsegmental atelectasis may occur due to mucus plugging or smooth muscle hypertrophy. Central bronchial wall thickening is common. Radiographs are helpful to exclude an acute abnormality such as pneumonia or pneumothorax.

Preferred Examination: CXR remains the initial imaging evaluation in most individuals with symptoms of asthma. The value of CXR is in revealing complications or alternative causes of wheezing and the minor importance of wheezing in the diagnosis of asthma and its exacerbations. CXR usually is more useful in the initial diagnosis of bronchial asthma than in the detection of exacerbations, although it is valuable in excluding complications such as pneumonia and asthma mimics, even during exacerbations.
High-resolution CT (HRCT) is a second-line examination. It is useful in patients with chronic or recurring symptoms and in those with possible complications such as allergic bronchopulmonary aspergillosis and bronchiectasis.
Limitations of Techniques: CXR is limited by frequent and sometimes subjective findings that are not specific for asthma; these nonspecific findings include airway thickening and hyperinflation. Nevertheless, in the appropriate clinical setting, CXR findings can support the diagnosis of asthma.
HRCT is more costly than CXR and exposes the patient to more radiation. Nevertheless, CT scans can demonstrate a number of findings that support the diagnosis of asthma; examples of such findings include bronchial wall thickening, bronchiectasis, mucoid impaction, and airtrapping, among others.

 

Pathology
Asthma is a chronic lung condition. It is characterized by difficulty in breathing.

People with asthma have extra sensitive or hyperresponsive airways. The airways react by narrowing or obstructing when they become irritated. This makes it difficult for the air to move in and out. This narrowing or obstruction can cause one or a combination of the following symptoms:
wheezing, coughing, shortness of breath, chest tightness
This narrowing or obstruction is caused by:
Airway inflammation (meaning that the airways in the lungs become red, swollen and narrow)
Bronchoconstriction (meaning that the muscles that encircle the airways tighten or go into spasm)
 

Pathophysiology:
Signs of asthma

Primarily, asthma is manifested by a sudden or prolonged onset of airway narrowing, which accounts for the varying degrees of airway obstruction and accompanying sensation of an inability to breathe in and, more importantly, to breathe out; these symptoms herald hyperinflation. The total lung capacity (TLC), functional residual capacity (FRC), and residual volume (RV) increase.

The hallmark of airway obstruction is a reduction in ratio of the forced expiratory volume in 1 second (FEV1) and the FEV1 to the forced vital capacity (FVC). However, the earliest effects of airway disease are believed to occur in the small airways (<2 mm in diameter), and they are more difficult to measure reliably with standard pulmonary function tests (PFTs), such as tests of the following: forced expiratory flow after 50% of vital capacity has been expelled (FEF50), forced expiratory flow after 25-75% of vital capacity has been expelled (FEF25-FEF75) and maximum midexpiratory flow rate (MMEFR). Less common evaluations include tests of airway resistance (RAW) and single-breath carbon monoxide diffusion capacity (DLCO/VA). With the former, resistance is markedly increased, although the findings are highly variable; with the latter, results are normal or slightly elevated in uncomplicated asthma (Collard, 1994; Boulet, 1995).

Whether the more severe and permanent features of distal airway obstruction and coexisting emphysema supervene in the later and more complicated stages of asthma is controversial. However, in one study, patients with partially reversible airway obstruction that persisted after optimal corticosteroid treatment had a normal diffusion capacity that was comparable to that of patients with completely reversible asthma (Hudon, 1997). The functional abnormalities reflect airway narrowing that results from multiple causes, including bronchial smooth muscle contraction; mucous plugging from mucous gland hypersecretion; submucosal, peribronchial, and interstitial edema from loss of capillary and arteriolar cellular interconnections; and cellular infiltrative changes involving plasma cells, lymphocytes, macrophages, and leukocytes.

Chronic or incompletely reversible asthma is characterized by variable obstruction; a more fixed degree of airway narrowing may also be present in some patients. With repeated episodes of clinically important airway narrowing, generalized thickening of the airways occurs as a result of smooth muscle hyperplasia, postinflammatory thickening of the bronchial basement membranes, and mucous gland hypertrophy.

Complications
Complications of asthma often are more apparent than the direct airway imaging findings that are the sequelae of asthma.

Spontaneous pneumothorax is an uncommon but well-recognized phenomenon.

The chest radiograph (CXR) is an important tool in the examination of patients with an exacerbation of asthma, but patients should not be left waiting in the treatment room for CXR before treatment (Swain, 1984).

Pneumothorax may be evident radiographically before it is identified clinically (Gay, 1978).

Pneumothorax often occurs during recurrent episodes of bronchospasm, as well as in other conditions. The presence of an air-fluid level in a hydropneumothorax can be confused with pneumatocele, infected cysts, and cavitary lung disease.

An unusual condition of diffuse pulmonary ossification associated with pneumothorax is described in a patient with bronchial asthma (Ikeda, 1998).

Pneumomediastinum can occur, particularly in young adults (see Images 1-2). The pathophysiologic nature of the process, as previously determined from animal studies, is reported (Jamadar, 1996). Using perfluorocarbon liquid ventilation in a hypoxic patient with status asthmaticus and tension pneumothorax, the authors traced the heavily radiopaque substance through ruptured alveoli, the interlobular spaces, and the axial interstitium to the mediastinum. The liquid agent remained in the interstitial space for 30 days without complications. Pneumomediastinum generally is self-limited, and it requires no additional therapeutic measures beyond those for asthma exacerbation (Ba-Ssalamah, 1999).

Emphysema can occur in the subdural space, especially in children. Air moves posteriorly from a pneumomediastinum into the intervertebral foramina and further into the most nondependent potential spaces adjacent to the brain coverings (Caramella, 1997). Spinal epidural emphysema is also described in asthmatics, tracking along the great vessels bound by the mediastinal pleural layers (Tsuji, 1989). As reported, these events typically have no neurologic sequelae.

Pneumopericardium is uncommon and more likely to occur in younger persons because their pericardial layers are more loosely apposed than those in adults (van der Klooster, 1998). As with pneumomediastinum, pneumopericardium generally has a benign course.

Pneumothorax, pneumomediastinum, pneumoretroperitoneum, pneumorrhachis (ie, spinal epidural air), and extensive subcutaneous emphysema are more likely to occur with episodes of coughing or increased intrathoracic pressure that accompany the recruitment of expiratory muscles when normal airflow is substantially reduced (van der Klooster, 1998).

More serious is subarachnoid hemorrhage, which developed in a patient with status asthmaticus who received ventilation with permissive hypercapnia. This technique minimizes the overall delivered minute ventilation and airway pressures to maintain adequate oxygenation. However, because of elevated CO2 partial pressures, it also led to cerebral vasodilatation and increased intracranial pressure; when combined with coughing spells and other forms of transmitted intrathoracic pressure, the ventilation was believed to promote cerebral edema and limit cerebral venous drainage (Rodrigo, 1999).

Noisy breathing may mask potential physical findings in pneumothorax, pneumomediastinum, and pneumonia; therefore, CXR should be performed prior to the use of mechanical ventilation.
 

Treatment:
Prescribed Treatments
Today's asthma treatments are extremely safe and effective. The doctor will work closely with you to devise a treatment plan that is tailored to your individual needs.

Preventers
The mainstay of your treatment will be with preventive drugs, known as preventers, which are designed to quell swelling and inflammation in the airways and reduce mucus. This reduces the sensitivity of the airways and so minmises potential damage.

The protective effect is built up gradually over a period of about a fortnight. Your medication must be taken daily to maintain protection, even if you are not experiencing symptoms. Most preventers are based on corticosteroids, usually known simply as steroids. These are completely different from the anabolic steroids sometimes used by body builders and athletes. Most common type of preventer are inhaled steroids. These can include beclomethasone, budesonide, fluticasome.

There are other non-steroid preventers, usually used for children, such as sodium cromoglycate and nedocromil sodium. They are usually taken 3-4 times a day, and are not generally as effective as steroids.

Potential side effects
Many people worry about the side effects of steroids. High doses of steroids taken over a long period can have significant side effects. For this reason, doctors will be careful to prescribe the lowest possible dose needed to control your asthma.

The main side effects are hoarseness and an increased risk of mouth and throat infections caused by thrush, a yeast that lives normally on the body's mucus membranes. Using the inhaler before brushing your teeth and rinsing your mouth out well afterwards helps to avoid this. Using a 'spacer' makes it easier to inhale the drug, and so helps reduce the risks of steroids being absorbed into your body.

Relievers
Relievers are drugs which relax and open up the airways - medically known as bronchodilators. These are prescribed for the relief of asthma symptoms during an actual asthma attack, when peak flow readings are low and before exercise or activity to reduce the risk of an attack. Because these drugs do not reduce swelling and inflammation of airways, you may also need to take a preventer.

Some relievers alleviate symptoms virtually instantly (rescue relievers). Others have a longer lasting action (long lasting relievers). The latter may be prescribed if wheezing, breathing difficulties and coughing persist despite using preventer and a rescue reliever - or if symptoms come on in the night (nocturnal asthma).

Common rescue relievers are salbutamol and terbutaline. Another type of reliever (most often prescribed for babies under two and for older people), called ipratropium bromide, takes about 45 minutes to take effect.

Long lasting relievers include oxitropum, salmeterol, and eformoterol, all of which are inhaled. Ocassionally theophylline-based drugs are taken by mouth, so tablets may be prescribed.

Potential side effects
Side effects are usually mild and pass away quickly. The main ones are a slightly increased heartbeat which may cause muscle trembling, especially in the hands. Some oral relievers may cause dry mouth, blurred vision, difficulties passing urine, or constipation. Theophyllin-based drugs can occasionally cause nausea, more rapid heartrate, a nettle-like rash, dizziness, nervousness, headaches, irritability, or restlessness. Always report any unusual symptoms to your doctor.

How asthma treatments are taken
Most asthma treatments are inhaled using a device called an inhaler. There are several different types, but the main ones are aerosol inhalers called puffers and dry powder inhalers:

'Puffers' - aerosol inhalers, metered dose inhalers, and breath-actuated inhalers. These are the most commonly used devices for treating asthma. The medication is mixed into a liquid and forced under pressure into a small aerosol canister. Once activated (usually by pushing down the canister), the liquid evaporates leaving the active ingredient which you inhale. A measured dose of the drug is released every time the canister if pushed down. Both relievers and preventers can be given via a puffer.


Dry powder inhalers - the drug which comes in dry powder former is contained in a capsule. When the device is activated the capsule breaks and the powder may be inhaled. In some the poswder is contained inside a disk or compartment.

'Spacers'
Because it can be hard to co-ordinate your breathing with an inhaler, you may be prescribed a spacer. This is a device that allows more medication to enter your lungs than would be possible using inhaler alone. It's usually a large canister in two halves that click together with a mouthpiece at one end, and at the other, a hole which is attached to an aerosol spray.

When you inhale, the drug is trapped in the space which is placed over the mouth - or the nose and mouth in the case of 'babyhalers.'

Nebulisers
A nebuliser is a machine in which air or oxygen is forced through the liquid form of a drug, creating a mist - which is then inhaled through a mask or mouthpiece. It is used to administer high doses of reliever in an emergency and sometimes for children who are too young to use inhaler. With the large number of inhalers and spacers now available, nebulisers are much less frequently used than they used to be. However they may be prescribed if you have severe, persistent asthma.

Oral medication
There are a number of medicines which are taken in pill form, including leukotriene receptor antagonists and steroid tablets. Your doctor will be able to advise you about when and why these are necessary for you.

Complementary treatments
Complementary treatments can play a part in the management of chronic asthma. However, because asthma is a potentially life-threatening condition, they should only ever be used as an adjunct to conventional medical treatment and never as the first line in an acute asthma attack. Homeopathy, Western herbalism, acupressure and acupuncture, and Chinese herbalism may all be useful.
Because asthma is a complex condition it is advisable to consult a qualified practitioner rather than trying to treat yourself. You should also make sure that your orthodox doctor is aware that you're having complementary treatment.
A variety of techniques to improve posture, encourage relaxation and improve breathing and strengthen the respiratory system may be useful, especially when used at the beginning of an attack to help calm you - or your child - and ease breathing. These include the Alexander technique, yoga, and a system of breathing known as Buteyko which unblocks the nose and stops mouth breathing and trains people with asthma not to overbreathe.


Taken From http://www.bbc.co.uk/health/asthma/

 

Image Asthma with upper lobe atelectasis

http://www.sh.lsumc.edu/